Arteriosclerosis Obliterans Clinical Trial
Official title:
Therapeutic Angiogenesis Using Cell Transplantation (TACT) Study at Nagoya
Clinical studies have established that implantation of bone marrow mononuclear cells (BM-MNCs) or peripheral blood mononuclear cells (PB-MNCs) into ischaemic limbs increases collateral vessel formation. We, the investigators at Nagoya University, further investigated the efficacy and safety of autologous implantation of BM-MNCs or PB-MNCs in patients with severe ischaemic limbs who have no other alternative therapeutic options. We also examined a potential limiting factor which reduced the efficacy of therapeutic angiogenesis using cell transplantation (TACT).
n/a
Observational Model: Defined Population, Time Perspective: Longitudinal
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00823849 -
Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker
|
Phase 4 | |
| Recruiting |
NCT00912756 -
Sufficient Treatment of Peripheral Intervention by Cilostazol
|
Phase 4 | |
| Completed |
NCT00712946 -
Preoperative Heart Rate Variability and Baroreflex Sensitivity in ASO Patients During Various Sleep Stages
|
N/A | |
| Enrolling by invitation |
NCT02864654 -
Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb Ischemia
|
Phase 1/Phase 2 | |
| Completed |
NCT05083299 -
Multicenter, Therapeutic Use Observational Study to Evaluate the Effects of Concurrent Therapy of Sarpogrelate
|
||
| Active, not recruiting |
NCT02431234 -
Arterial Calcification in the Diabetes
|
||
| Completed |
NCT01518205 -
HELP-Apheresis in Diabetic Ischemic Foot Treatment (H.A.D.I.F)
|
N/A | |
| Recruiting |
NCT02877173 -
A Safety/Efficacy Study of Alprostadil Liposomes for Injection to Treat Lower Extremity Arteriosclerosis Obliterans
|
Phase 2 |